Interestingly, in our study, AIM2 seemed to be a cancer-promoting gene, as it was upregulated threefold in tumour tissues; however, it also contributed to prolonged patient survival because it was enriched in the low-risk group. This evidence concerns the gene AIM2 and cancer.